UMIN000048208Completed
Exploratory study on determinant of pharmacokinetics of monoclonal antibodies in patients with advanced gastric cancer
Keio UniversityUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Gastric cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Keio University
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 01, 2017
- End date
- N/A
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048208
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048208 through Pure Global AI's free database. This phase not specified trial is sponsored by Keio University and is currently Completed. The study focuses on Gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.